Petra Pharma, a drug development company focused on novel enzyme targets, and Schrödinger, Inc., a privately-held company dedicated to revolutionizing drug discovery through advanced computational methods, today announced a research collaboration to develop new therapeutic treatment options for patients who suffer from cancer and metabolic diseases.